CELF4 p.Ala211Glu
c.632C>A · VCV4651865
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7263 | likely pathogenic |
|---|---|---|
| REVEL | 0.157 | moderately benign-leaning |
| SaProt | LLR -14.61 | damaging |
| ⇒ AlphaMissense and SaProt call this damaging; REVEL does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 9.8 | GERP 1.2, phastCons 1 |
| Regional constraint | o/e 0.61 | unconstrained · MANE · 765 bp · p 0.00017 · regional, not allelic |
| Overall | ||
| CADD | 28.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00224% | 44,648 |
| European (non-Finnish) | 8.49e-05% | 1,177,831 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CELF4
- Protein
- p.Ala211Glu
- Coding
- c.632C>A
- MANE Select
- NM_020180
- Type
- single nucleotide variant
- Location
- chr18:37274830 (GRCh38)
- Gene constraint
- LOEUF 0.546 · pLI 0.84 · ClinGen HI 1/3 (gnomAD)
- Structure
- AlphaFold pLDDT 62.70 · 2 PDB
- Residue 211
- the rrm 2 domain; an α-helix; the 'sufficient for rna-binding and mse-dependent splicing activity' region
Similar variants
- CELF4 p.Ala211Gly Uncertain significance ★ ⚠ same residue
- CELF4 p.Ala211Thr Uncertain significance ★ ⚠ same residue
- CELF4 p.Gly193Val Uncertain significance ★★ ⚠ same type
- CELF4 p.Ala381= Benign/Likely benign ★★ same type
- CELF4 p.Pro127= Benign ★★ same type
- CELF4 p.Pro406= Benign ★★ same type
- CELF4 p.Glu76Ter Pathogenic ★ same type
- CELF4 c.1165+2T>C Uncertain significance ★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/celf4-p-ala211glu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown